Internal Medicine · Baltimore, MD
NPI
1972568426
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1717 E Monument St
Baltimore, MD, 21287
Phone (410) 955-1725
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
506 services
Medicare patients, 2024
120
Average age 64
Drug cost, 2024
$5.5M
6,247 prescriptions
Company payments, 2025
$92.96
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christie Basseth was code 99214 (office e&m - established), 303 times for 108 patients. In total Christie Basseth billed 506 services in 11 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 303 | 108 | $44.82 | $14K |
| 99213 Office E&M - Established | Facility | 71 | 48 | $38.17 | $2,710 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 71 | 71 | $134.60 | $9,557 |
| 99215 Office E&M - Established | Facility | 34 | 30 | $51.08 | $1,737 |
By year: 2022 $37K for 455 services; 2023 $32K for 461 services; 2024 $30K for 506 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christie Basseth prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 513 prescriptions and refills. In total Christie Basseth wrote 6,247 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 513 | 513 | 55 | $1.9M |
| Atorvastatin Calcium Generic | 495 | 718 | 79 | $1,932 |
| Amlodipine Besylate Generic | 275 | 347 | 40 | $649 |
| Gabapentin Generic | 226 | 253 | 26 | $1,401 |
| Pifeltro Doravirine | 207 | 209 | 21 | $345K |
| Tivicay Dolutegravir Sodium | 188 | 188 | 19 | $403K |
| Metformin Hcl Er Metformin Hcl | 161 | 196 | 24 | $638 |
| Juluca Dolutegravir/Rilpivirine | 140 | 148 | 15 | $496K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 126 | 126 | 23 | $4,698 |
| Rosuvastatin Calcium Generic | 124 | 166 | 17 | $699 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 113 | 113 | 11 | $422K |
| Nifedipine Er Nifedipine | 106 | 144 | 12 | $1,279 |
| Metoprolol Succinate Generic | 104 | 146 | 16 | $945 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 103 | 103 | Under 11 | $362K |
| Losartan Potassium Generic | 102 | 166 | 17 | $623 |
Brand drugs: 2,267 claims; generic drugs: 3,923 claims; opioid claims: 214.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christie Basseth $92.96 ($92.96 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $92.96.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $92.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.